These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
544 related articles for article (PubMed ID: 20542480)
21. Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting: risks of breast/ovarian cancer quoted should reflect the cancer burden in the family. Evans DG; Shenton A; Woodward E; Lalloo F; Howell A; Maher ER BMC Cancer; 2008 May; 8():155. PubMed ID: 18513387 [TBL] [Abstract][Full Text] [Related]
22. Hereditary breast cancer; Genetic penetrance and current status with BRCA. Mahdavi M; Nassiri M; Kooshyar MM; Vakili-Azghandi M; Avan A; Sandry R; Pillai S; Lam AK; Gopalan V J Cell Physiol; 2019 May; 234(5):5741-5750. PubMed ID: 30552672 [TBL] [Abstract][Full Text] [Related]
24. The penetrance of ductal carcinoma in situ among BRCA1 and BRCA2 mutation carriers. Mazzola E; Cheng SC; Parmigiani G Breast Cancer Res Treat; 2013 Jan; 137(1):315-8. PubMed ID: 23184082 [TBL] [Abstract][Full Text] [Related]
25. Polyglutamine repeat length in the AIB1 gene modifies breast cancer susceptibility in BRCA1 carriers. Kadouri L; Kote-Jarai Z; Easton DF; Hubert A; Hamoudi R; Glaser B; Abeliovich D; Peretz T; Eeles RA Int J Cancer; 2004 Jan; 108(3):399-403. PubMed ID: 14648706 [TBL] [Abstract][Full Text] [Related]
27. Double heterozygosity in the BRCA1 and BRCA2 genes in the Jewish population. Lavie O; Narod S; Lejbkowicz F; Dishon S; Goldberg Y; Gemer O; Rennert G Ann Oncol; 2011 Apr; 22(4):964-966. PubMed ID: 20924075 [TBL] [Abstract][Full Text] [Related]
28. The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations. Satagopan JM; Offit K; Foulkes W; Robson ME; Wacholder S; Eng CM; Karp SE; Begg CB Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):467-73. PubMed ID: 11352856 [TBL] [Abstract][Full Text] [Related]
29. Prevalence and spectrum of germline rare variants in BRCA1/2 and PALB2 among breast cancer cases in Sarawak, Malaysia. Yang XR; Devi BCR; Sung H; Guida J; Mucaki EJ; Xiao Y; Best A; Garland L; Xie Y; Hu N; Rodriguez-Herrera M; Wang C; Jones K; Luo W; Hicks B; Tang TS; Moitra K; Rogan PK; Dean M Breast Cancer Res Treat; 2017 Oct; 165(3):687-697. PubMed ID: 28664506 [TBL] [Abstract][Full Text] [Related]
30. No association of TGFB1 L10P genotypes and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a multi-center cohort study. Rebbeck TR; Antoniou AC; Llopis TC; Nevanlinna H; Aittomäki K; Simard J; Spurdle AB; ; Couch FJ; Pereira LH; Greene MH; Andrulis IL; ; Pasche B; Kaklamani V; ; Hamann U; Szabo C; Peock S; Cook M; Harrington PA; Donaldson A; Male AM; Gardiner CA; Gregory H; Side LE; Robinson AC; Emmerson L; Ellis I; ; Peyrat JP; Fournier J; Vennin P; Adenis C; Muller D; Fricker JP; Longy M; Sinilnikova OM; Stoppa-Lyonnet D; ; Schmutzler RK; Versmold B; Engel C; Meindl A; Kast K; Schaefer D; Froster UG; Chenevix-Trench G; Easton DF Breast Cancer Res Treat; 2009 May; 115(1):185-92. PubMed ID: 18523885 [TBL] [Abstract][Full Text] [Related]
31. The CASP8 rs3834129 polymorphism and breast cancer risk in BRCA1 mutation carriers. Catucci I; Verderio P; Pizzamiglio S; Manoukian S; Peissel B; Zaffaroni D; Roversi G; Ripamonti CB; Pasini B; Barile M; Viel A; Giannini G; Papi L; Varesco L; Martayan A; Riboni M; Volorio S; Radice P; Peterlongo P Breast Cancer Res Treat; 2011 Feb; 125(3):855-60. PubMed ID: 20652397 [TBL] [Abstract][Full Text] [Related]
32. Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families. Levy-Lahad E; Catane R; Eisenberg S; Kaufman B; Hornreich G; Lishinsky E; Shohat M; Weber BL; Beller U; Lahad A; Halle D Am J Hum Genet; 1997 May; 60(5):1059-67. PubMed ID: 9150153 [TBL] [Abstract][Full Text] [Related]
33. Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study. Hopper JL; Southey MC; Dite GS; Jolley DJ; Giles GG; McCredie MR; Easton DF; Venter DJ Cancer Epidemiol Biomarkers Prev; 1999 Sep; 8(9):741-7. PubMed ID: 10498392 [TBL] [Abstract][Full Text] [Related]
34. Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers. Cullinane CA; Lubinski J; Neuhausen SL; Ghadirian P; Lynch HT; Isaacs C; Weber B; Moller P; Offit K; Kim-Sing C; Friedman E; Randall S; Pasini B; Ainsworth P; Gershoni-Baruch R; Foulkes WD; Klijn J; Tung N; Rennert G; Olopade O; Couch F; Wagner T; Olsson H; Sun P; Weitzel JN; Narod SA Int J Cancer; 2005 Dec; 117(6):988-91. PubMed ID: 15986445 [TBL] [Abstract][Full Text] [Related]
35. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Antoniou A; Pharoah PD; Narod S; Risch HA; Eyfjord JE; Hopper JL; Loman N; Olsson H; Johannsson O; Borg A; Pasini B; Radice P; Manoukian S; Eccles DM; Tang N; Olah E; Anton-Culver H; Warner E; Lubinski J; Gronwald J; Gorski B; Tulinius H; Thorlacius S; Eerola H; Nevanlinna H; Syrjäkoski K; Kallioniemi OP; Thompson D; Evans C; Peto J; Lalloo F; Evans DG; Easton DF Am J Hum Genet; 2003 May; 72(5):1117-30. PubMed ID: 12677558 [TBL] [Abstract][Full Text] [Related]
37. BRCA1 and BRCA2 mutation carriers in the Breast Cancer Family Registry: an open resource for collaborative research. Neuhausen SL; Ozcelik H; Southey MC; John EM; Godwin AK; Chung W; Iriondo-Perez J; Miron A; Santella RM; Whittemore A; Andrulis IL; Buys SS; Daly MB; Hopper JL; Seminara D; Senie RT; Terry MB; Breast Cancer Res Treat; 2009 Jul; 116(2):379-86. PubMed ID: 18704680 [TBL] [Abstract][Full Text] [Related]
38. Breast cancer prognosis in BRCA1 and BRCA2 mutation carriers: an International Prospective Breast Cancer Family Registry population-based cohort study. Goodwin PJ; Phillips KA; West DW; Ennis M; Hopper JL; John EM; O'Malley FP; Milne RL; Andrulis IL; Friedlander ML; Southey MC; Apicella C; Giles GG; Longacre TA J Clin Oncol; 2012 Jan; 30(1):19-26. PubMed ID: 22147742 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of chromosome 6p22 as a breast cancer risk modifier locus in a follow-up study of BRCA2 mutation carriers. Stevens KN; Wang X; Fredericksen Z; Pankratz VS; Greene MH; Andrulis IL; Thomassen M; Caligo M; ; Nathanson KL; Jakubowska A; Osorio A; Hamann U; Godwin AK; Stoppa-Lyonnet D; Southey M; Buys SS; Singer CF; Hansen TV; Arason A; Offit K; Piedmonte M; Montagna M; Imyanitov E; Tihomirova L; Sucheston L; Beattie M; ; ; Neuhausen SL; ; Szabo CI; ; Simard J; Spurdle AB; Healey S; Chen X; Rebbeck TR; Easton DF; Chenevix-Trench G; Antoniou AC; Couch FJ Breast Cancer Res Treat; 2012 Nov; 136(1):295-302. PubMed ID: 23011509 [TBL] [Abstract][Full Text] [Related]
40. Mutations in BRCA1, BRCA2 and other breast and ovarian cancer susceptibility genes in Central and South American populations. Jara L; Morales S; de Mayo T; Gonzalez-Hormazabal P; Carrasco V; Godoy R Biol Res; 2017 Oct; 50(1):35. PubMed ID: 28985766 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]